Key result
Higher total bilirubin is linked to ~4% higher stroke risk per 1 µmol/L in NVAF.
Why the study?
The relationship between serum total bilirubin levels and initial ischemic stroke risk in patients with non-valvular atrial fibrillation was unclear.
Cohort (n=316)
No
Hazard Ratio: 1.04 (95% CI 1.01–1.07)
p-value: p=0.018
Bilirubin elevation was associated with higher stroke risk in non-valvular AF; hypothesis-generating and should not yet change practice.
OBJECTIVE: This study aimed to examine the relationship between total bilirubin levels and initial ischemic stroke in patients with non-valvular atrial fibrillation. METHODS: This was a retrospective study. Atrial fibrillation was diagnosed by 24-hour Holter electrocardiography and serum total bilirubin levels were divided into quintiles. Ischemic stroke was diagnosed by symptoms, signs, and a medical image examination. The multivariate Cox proportional hazards model and survival analysis were used to estimate the association of total bilirubin with initial ischemic stroke. RESULTS: We studied 316 patients with non-valvular atrial fibrillation. During follow-up, there were 42 (13.29%) first ischemic strokes. After multivariate adjustment, for each 1 µmol/L increase in total bilirubin, the risk of first ischemic stroke increased by 4% (95% confidence interval [CI]: 1.01, 1.07). When using the first quintile as the reference, from the second to fifth quintiles, the risks of first ischemic stroke were 0.52 (95% CI: 0.17, 1.65), 0.23 (95% CI: 0.06, 0.87), 0.92 (95% CI: 0.32, 2.67), and 1.33 (95% CI: 1.09, 4.41), respectively. The optimal cut-off point of total bilirubin for the lowest risk of ischemic stroke was 17.0 µmol/L. CONCLUSIONS: Total bilirubin levels are nonlinearly associated with initial ischemic stroke in patients with non-valvular atrial fibrillation.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2020) conducted a cohort in Non-valvular atrial fibrillation (n=316). Serum total bilirubin levels vs. Lower serum total bilirubin levels (first quintile or <17.0 µmol/L) was evaluated on First ischemic stroke (HR 1.04, 95% CI 1.01-1.07, p=0.018). In patients with non-valvular atrial fibrillation, each 1 µmol/L increase in serum total bilirubin increased the risk of first ischemic stroke by 4% (HR 1.04), with risk significantly increasing at levels ≥17.0 µmol/L.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: